Cathelicidin LL-37: A new important molecule in the pathophysiology of systemic lupus erythematosus

Cathelicidin LL-37: A new important molecule in the pathophysiology of systemic lupus erythematosus

Cathelicidin LL-37 is an antimicrobial peptide that is synthesized by epithelial cells, neutrophils, or lymphocytes and act as an essential defense mechanism against bacterial, viral, or fungi infection of eukaryotic organisms. However, in recent years, this cathelicidin has gained the interest of t...

Full description

Bibliographic Details
Main Authors:	Alejandro Moreno-Angarita, Cristian C. Aragón, Gabriel J. Tobón
Format:	Article
Language:	English
Published:	Elsevier 2020-01-01
Series:	Journal of Translational Autoimmunity
Subjects:	LL-37 Cathelicidin Antibodies Antigen NETosis Lupus
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589909019300292

Similar Items

Evaluating the Antiviral Activities of Human Cathelicidin LL-37 Peptide Against Rotavirus in Vitro
by: Zohreh Hosseini, et al.
Published: (2019-08-01)

The human cathelicidin antimicrobial peptide LL-37 and mimics are potential anticancer drugs
by: Kengo eKuroda, et al.
Published: (2015-06-01)

Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections
by: Bapi Pahar, et al.
Published: (2020-09-01)

Citrullination Alters the Antiviral and Immunomodulatory Activities of the Human Cathelicidin LL-37 During Rhinovirus Infection
by: Víctor Casanova, et al.
Published: (2020-02-01)

Roles and Mechanisms of Human Cathelicidin LL-37 in Cancer
by: Xi Chen, et al.
Published: (2018-05-01)

Colonic epithelial cathelicidin (LL‐37) expression intensity is associated with progression of colorectal cancer and presence of CD8+ T cell infiltrate
by: Ross J Porter, et al.
Published: (2021-09-01)

Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections
by: Karol Majewski, et al.
Published: (2018-12-01)

The Role of T Cells Reactive to the Cathelicidin Antimicrobial Peptide LL-37 in Acute Coronary Syndrome and Plaque Calcification
by: Fernando Chernomordik, et al.
Published: (2020-10-01)

Sphingosine‐1‐Phosphate‐Triggered Expression of Cathelicidin LL‐37 Promotes the Growth of Human Bladder Cancer Cells
by: Bucki, R., et al.
Published: (2022)

The serum level of the immunomodulatory peptide cathelicidin LL37 and T helper cell type 1 inflammatory response in viral hepatitis B, C, and D
by: Iacob Simona Alexandra, et al.
Published: (2013-03-01)

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
by: Ibrahim H. Babikir, et al.
Published: (2018-01-01)

Evaluation of LL 37 Lipoprotein As Innate Immunity Marker among Sudanese Patients Cutaneous Leishmania
by: Ayat H. Bakr, et al.
Published: (2019-09-01)

Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures
by: Kornelius Zeth, et al.
Published: (2021-05-01)

Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications
by: Urszula Wnorowska, et al.
Published: (2020-01-01)

CXCR2 specific endocytosis of immunomodulatory peptide LL-37 in human monocytes and formation of LL-37 positive large vesicles in differentiated monoosteophils
by: Zhifang Zhang, et al.
Published: (2020-06-01)

Complementary Effects of Carbamylated and Citrullinated LL37 in Autoimmunity and Inflammation in Systemic Lupus Erythematosus
by: Roberto Lande, et al.
Published: (2021-02-01)

Vitamin D, serum 25(OH)D, LL-37 and polymorphisms in a Canadian First Nation population with endemic tuberculosis
by: Linda Larcombe, et al.
Published: (2015-08-01)

Immunomodulatory Functions of the Human Cathelicidin LL-37 (aa 13–31)-Derived Peptides are Associated with Predicted α-Helical Propensity and Hydrophobic Index
by: Mahadevappa Hemshekhar, et al.
Published: (2019-09-01)

Effects of cigarette smoke on barrier function and tight junction proteins in the bronchial epithelium: protective role of cathelicidin LL-37
by: Miyoko Tatsuta, et al.
Published: (2019-11-01)

Cathelicidin LL37 Promotes Osteogenic Differentiation in vitro and Bone Regeneration in vivo
by: Lunhao Li, et al.
Published: (2021-05-01)

Multiple immune-modulatory functions of cathelicidin host defence peptides
by: Ka-Yee Grace Choi, et al.
Published: (2012-06-01)

Chitosan hydrogel encapsulated with LL-37 peptide promotes deep tissue injury healing in a mouse model
by: Xu Yang, et al.
Published: (2020-04-01)

LEVELS OF LL-37 ANTIMICROBIAL PEPTIDE IN THE GINGIVAL CREVICULAR FLUID OF YOUNG AND MIDDLE-AGED SUBJECTS WITH OR WITHOUT GINGIVITIS
by: Oya TÜRKOĞLU, et al.
Published: (2017-01-01)

Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury
by: Yihua Bei, et al.
Published: (2019-02-01)

Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults
by: Dixon Brian M, et al.
Published: (2012-10-01)

Cathelicidins Modulate TLR-Activation and Inflammation
by: Maaike R. Scheenstra, et al.
Published: (2020-06-01)

Circulating Antimicrobial Peptide LL-37 Status in Type 1 Diabetes Mellitus and its Relation with Glycemic Control
by: Himika Chawla, et al.
Published: (2017-04-01)

Does peri-implant bone loss affect the LL-37 and proteinase 3 levels in peri-implant sulcus fluid?
by: Oya Turkoglu, et al.
Published: (2020-08-01)

The role of human β-defensin 2 (HbD-2) and cathelicidin (LL-37) in the local protection of the upper respiratory tract in children with allergic rhinitis and bronchial asthma
by: Yu.K. Bolbot, et al.
Published: (2021-03-01)

Short-Term versus Long-Term Culture of A549 Cells for Evaluating the Effects of Lipopolysaccharide on Oxidative Stress, Surfactant Proteins and Cathelicidin LL-37
by: Zuzana Nova, et al.
Published: (2020-02-01)

Microencapsulation of LL-37 Antimicrobial Peptide in PLGA
by: El Abbouni, Sarah
Published: (2016)

The Role of Antimicrobial Peptides in Influenza Virus Infection and Their Potential as Antiviral and Immunomodulatory Therapy
by: I-Ni Hsieh, et al.
Published: (2016-09-01)

Vitamin D Deficiency and Air Pollution Exacerbate COVID-19 Through Suppression of Antiviral Peptide LL37
by: Mardi A. Crane-Godreau, et al.
Published: (2020-05-01)

The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
by: Kylen E. Ridyard, et al.
Published: (2021-05-01)

Cathelicidin Contributes to the Restriction of Leishmania in Human Host Macrophages
by: Peter Crauwels, et al.
Published: (2019-11-01)

Spotlight on Human LL-37, an Immunomodulatory Peptide with Promising Cell-Penetrating Properties
by: Marc Ferdinand Lensink, et al.
Published: (2010-11-01)

Study of serum level of cathelicidin in patients with inflammatory bowel disease and its correlation to disease activity
by: Abeer A Mohamed, et al.
Published: (2020-01-01)

Cathelicidin peptide rescues G. mellonella infected with B. anthracis
by: Ryan J. Blower, et al.
Published: (2018-12-01)

Design and Study of Collagen-Tethered LL37 for Chronic Wound Healing
by: Lozeau, Lindsay Dawn
Published: (2018)

Immunomodulatory effects of LL-37 in the epithelia
by: Filewod, Niall Christopher Jack
Published: (2008)

Cannot write session to /tmp/vufind_sessions/sess_taulll8gp0ba89su9l5p5n912p